Stockpickr! Your Source for Stock Ideas

Blogs about GSK

Blogs	Description	Date Updated
Trade idea for Glaxo (GSK) downgrade	Filed under: Analyst upgrades and downgrades, Bad news, Options, Technical AnalysisGlaxoSmithKline (NYSE: GSK) shares are falling after Morgan Stanley downgraded the stock to "Underweight" from "Equalweight," citing pessimism on the chances GSK's Cervarix drug will gain FDA approval in 2009.If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on GSK. After hitting a one-year high of $54.64 in January, the stock hit a...	May 27, 2008
Analyst downgrades: General Motors, Anheuser-Busch, GlaxoSmithKline	Filed under: Analyst reports, Analyst upgrades and downgrades, General Motors (GM), Anheuser-Busch Cos (BUD), China Mobile Limited (CHL)MOST NOTEWORTHY: General Motors, Anheuser-Busch and GlaxoSmithKline were today's noteworthy downgrades. Citigroup downgraded shares of General Motors Corporation (NYSE: GM) to Hold from Buy to reflect reduced earnings power and cash burn risks and recommends swapping into American Axle & Manufacturing Holdings Inc (NYSE: AXL). Deutsche Bank cut ...	May 27, 2008
Fast Money Recap	Word On The StreetWORD ON THE STREET VIDEODonny Deutsch Trade - Big Business Exploits Small BrandsDonny Deutsch, the host of CNBC's "Big Idea" joined the traders to discuss some trends he is seeing with big businesses buying small brands. He said Coke (KO) is buying into vitamin water and he thinks the upside is huge. He warned investors that once the the brand starts to feel generic or loses its entrepreneurial spirit than get out. He advised investor to watch what Clorox (CLX) does with Burt's...	May 15, 2008
Biotech Business Daily (GSK, MRK, OMPI, STEM, TEVA, VNDA)	Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	May 06, 2008
Europe Markets 5/6/2008 (GSK)(SAP)	Markets in Europe were off modestly at 6.40 AM New York time. The FTSE dropped .6% to 6,181. British Airways was off 3.8% to 239.25. GlaxoSmithKline (GSK) was... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	May 06, 2008
Market highlights for next week: April sales results coming out	Filed under: Earnings reports, Conventions and conferences, Annual meetings, Wal-Mart (WMT), Walt Disney (DIS), Target Corp. (TGT), Amer Intl Group (AIG), Abercrombie and Fitch (ANF), Sotheby's (BID), Anadarko Petroleum (APC)Monday, May 5 Happy Cinco de Mayo! Day one of the two-day FDA Anesthetic/Life Support Drugs & Drug Safety/Risk Management Advisory Committees meeting: Purdue Pharma's NDA for Oxycontin. Anadarko Petroleum (NYSE:APC) to report Q1 earnings; conference cal...	May 02, 2008
Glaxo-Smith Kline heart drug gets FDA approval	Filed under: Good news, Options, Technical AnalysisGlaxoSmithKline (NYSE: GSK) shares are trading higher after the Food and Drug Administration approved GSK's Advair Diskus 250/50 for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Advair is now the only FDA-approved treatment for the reduction of COPD exacerbations. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trad...	May 01, 2008
Jacobs Engineering Group (JEC): Shares define bullish 'cup & handle'	Filed under: Earnings reports, Ford Motor (F), Technical Analysis, Stocks to BuyJacobs Engineering Group (NYSE: JEC) provides technical, professional, and construction services to industrial, commercial, and governmental customers worldwide. The company designs and engineers process plants, buildings, infrastructure projects and manufacturing facilities. It also provides operations and maintenance services. Clients include Ford Motor (NYSE: F), GlaxoSmithKline (NYSE: GSK) and the US Department o...	April 28, 2008
Sirtris Major Buyout Premium From GlaxoSmithKline, Public Under a Year (SIRT, GSK)	GlaxoSmithKline (NYSE: GSK) has announced that it has entered into a definitive acquisition pact with Sirtris Pharmaceuticals Inc. (NASDAQ: SIRT). The drug... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	April 22, 2008
Depressed About Stocks? How about Anti-Depression Drug Stocks?	In the United States, approximately 14 million adults per year are affected by depression, and according to the World Health Organization, depression causes the suffering of an estimated 121 million people throughout the world and is expected to become the second leading cause of disability worldwide by the year 2020. With these numbers, the demand for antidepressants is expected to grow significantlyEli Lilly & Co. (LLY) has the eighth best selling drug, Zyprexa, used to treat schizophrenia, an...	April 21, 2008

Enter search text here: